2型糖尿病患者伴有毛霉菌肺炎临床治疗的药学监护

Pharmaceutical Care of Clinical Medication in Type 2 Diabetes Mellitus Patients with Mucormycosis Pneumonia

目的:分析2型糖尿病患者伴有毛霉菌肺炎临床治疗的药学监护,为2型糖尿病患者伴有毛霉菌肺炎临床合理用药提供参考。方法:临床药师参与临床会诊,提出个体化治疗方案,并对治疗过程实施全程监护。结果:临床药师参与2型糖尿病患者伴有毛霉菌肺炎的临床抗感染治疗病例中,提出的个体化用药建议是合理的、有效的。结论:通过临床药师参与毛霉菌肺炎患者两性霉素B及其脂质体抗感染治疗过程,有效控制了血糖值,及时发现患者治疗中存在的不合理之处,提高了药物治疗的安全性和有效性。

Objective: To analyze the pharmaceutical care of medication in type 2 diabetes mellitus patients with Mucormycosis pneumonia, and to provide reference for rational drug usage in clinic. Methods: Clinical pharmacist participated in clinical consultation, proposed individualized treatment plan, and monitored the whole course of treatment.Results: In the clinical anti-infection treatment of type 2 diabetes mellitus patient with Mucormycosis pneumonia, the individualized medication suggestions put forward by clinical pharmacist were reasonable and effective. Conclusion:The blood glucose of type 2 diabetes mellitus patients with mucormycosis pneumonia was effectively controlled through participation of clinical pharmacist in anti-infective treatment process with amphotericin B and liposomes. Discovering the unreasonable medication in time could improve the safety and effectiveness of clinc drug treatment.